Business · 1 sources covering this

Morepen Laboratories files its first US ANDA for sitagliptin tablets

The filing for sitagliptin tablets in three strengths marks Morepen's entry into integrated finished-dose development and regulatory filings in the US market

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Morepen Laboratories files its first US ANDA for sitagliptin tablets
The filing for sitagliptin tablets in three strengths marks Morepen's entry into integrated finished-dose development and regulatory filings in the US market
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/2b47303e3b32f8b5cc73e86a3cae32da13a7cf4a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Morepen Laboratories files its first US ANDA for sitagliptin tablets"></iframe>

Morepen Laboratories files its first US ANDA for sitagliptin tablets

How 1 sources are covering this

Morepen Laboratories files its first US ANDA for sitagliptin tablets

More from Business

Nvidia $150 billion buyback: Why Jensen Huang is betting on AI growth

MTV VMAs 2026 Winners List: Taylor Swift, BTS Shine; Madonna Takes Top Honours

Who is Parvesh Verma? Delhi PWD minister involved in Tilak Nagar road inspection slap controversy

Asiad 2026: Yashvir wins silver, Rohit claims bronze in men's javelin final

Reader

Trust & legal

Across the network